| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | ₹1.15 -11.53% | 20,925-3.57% |
| 00% | ₹126.7 0% | 820 | ₹1.95 -11.36% | 66,65017.80% |
| - | - | 840 | ₹4.75 0% | 31,0000% |
| - | - | 850 | ₹2.8 -26.31% | 16,2750% |
| - | - | 860 | ₹3.35 -15.18% | 22,4753.57% |
| - | - | 870 | ₹5.35 0% | 6,2000% |
| 7750% | ₹76.15 0% | 880 | ₹5.05 -9.82% | 59,6751.31% |
| 2,3250% | ₹71.65 0% | 890 | - | - |
| 20,1500% | ₹66.15 19.83% | 900 | ₹7.95 -15.87% | 2,01,5006.99% |
| 2,3250% | ₹49.7 18.33% | 920 | ₹13.55 -1.45% | 33,3257.5% |
| 51,1500% | ₹35.8 0% | 930 | ₹16.25 -11.44% | 25,5756.45% |
| 20,92512.5% | ₹36 6.98% | 940 | ₹20.2 -10.22% | 76,7251.02% |
| 1,48,02569.02% | ₹31 15.24% | 950 | ₹24 -11.92% | 95,32543.02% |
| 1,06,17529.24% | ₹25.65 10.32% | 960 | ₹28.05 -7.42% | 48,05014.81% |
| 3,1000% | ₹18.75 0% | 970 | ₹37 0% | 7,7500% |
| 28,675-9.75% | ₹17.65 17.66% | 980 | ₹47.35 0% | 20,9250% |
| 10,07585.71% | ₹13.4 5.09% | 990 | ₹49.85 0% | 7750% |
| 2,46,45026.69% | ₹11.4 15.15% | 1,000 | ₹62.95 0% | 21,7000% |
| 00% | ₹8.4 -16% | 1,010 | ₹64.45 0% | 1,5500% |
| 83,7005.88% | ₹7.1 14.51% | 1,020 | - | - |
| 3,8750% | ₹23.15 0% | 1,030 | - | - |
| 21,70040% | ₹4.35 -15.53% | 1,040 | - | - |
| 1,5500% | ₹3.25 0% | 1,050 | - | - |
| 1,5500% | ₹15.5 0% | 1,060 | - | - |
| 3,1000% | ₹3.05 0% | 1,080 | - | - |
| 7750% | ₹7 0% | 1,100 | - | - |
| 7,7500% | ₹1.2 0% | 1,120 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
